As of the end of November 2021, we identify the following trends in Europe:
- The overall price development of the European therapeutics sector rose by an average of +20% last year
- Within the Therapeutics Sector, the Infectious Diseases sector recorded the highest share price performance within the last year with +125%, followed by Ophthalmology (+109%) and Respiratory (+52%)
- Analysts see an average upside potential of +130% in the share prices of the European Therapeutics Sector
Capital Markets Research
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 09/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024”. The Monitor is a monthly published overview of venture capital trends in
